Severe Octreotide-Induced Immune Thrombocytopenia With Bone Marrow Findings Suggestive of Acquired Amegakaryocytic Thrombocytopenic Purpura in a Cirrhotic Woman: An Unusual Case Report
Open Access
- 16 November 2025
- journal article
- Published by Springer Nature in Cureus
- Vol. 17 (11)
Abstract
Drug-induced immune thrombocytopenia (DIT) is a rare but potentially life-threatening condition that is often underrecognized in clinical practice. Octreotide, a somatostatin analogue used to control GI bleeding, has rarely been associated with DIT. We describe an 80-year-old woman with metabolic cirrhosis and chronic thrombocytopenia who developed profound thrombocytopenia and severe bleeding shortly after initiating octreotide. Bone marrow evaluation revealed marked megakaryocytic hypoplasia, initially suggestive of acquired amegakaryocytic thrombocytopenic purpura (AATP). Antiplatelet antibodies were detected, and the patient responded rapidly to dexamethasone, intravenous immunoglobulin, and eltrombopag. Although the presentation resembled classic DIT, the marrow findings and clinical course suggested overlapping features of AATP and bone marrow aplasia. This case underscores the diagnostic challenges of thrombocytopenia in cirrhosis, the potential suppressive effect of octreotide on megakaryopoiesis, and the importance of early marrow assessment and immunosuppressive therapy in severe cases.Keywords
This publication has 9 references indexed in Scilit:
- Acquired amegakaryocytic thrombocytopenic purpura: a review of therapeutic optionsHematology/Oncology and Stem Cell Therapy, 2023
- Drug-Associated Thrombocytopenia as a Rare and Devastating Side Effect of Octreotide in a Cirrhotic Patients: A Case Report and Current Literature ReviewMedical Bulletin of Haseki, 2021
- Acquired amegakaryocytic thrombocytopenia after durvalumab administrationJournal of Clinical and Experimental Hematopathology, 2021
- Acquired Amegakaryocytic Thrombocytopenia Misdiagnosed as Immune Thrombocytopenia: A Case ReportThe Permanente Journal, 2020
- Thrombocytopenia in chronic liver diseaseLiver International, 2016
- Octreotide-induced thrombocytopenia: a case reportJournal of Medical Case Reports, 2011
- Drug-induced immune thrombocytopenia: pathogenesis, diagnosis, and managementJournal of Thrombosis and Haemostasis, 2009
- Drug-Induced Immune ThrombocytopeniaNew England Journal of Medicine, 2007
- Drug-Induced Immune ThrombocytopeniaDrug Safety, 2004